View in EDS HTML Full Text PDF Full Text

Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer's disease.
Authors: Meyer C; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Niedermeier T; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Feyen PLC; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany., Strübing FL; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany., Rauchmann BS; Institute of Neuroradiology, LMU Hospital, LMU Munich, Munich, Germany.; Department of Psychiatry and Psychotherapy, LMU Hospital, LMU Munich, Munich, Germany., Karali K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Gentz J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany., Tillmann YE; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany., Landgraf NF; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany.; Graduate School of Systemic Neurosciences, LMU Munich, Munich, Germany., Rumpf SL; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Ochs K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany., Wind-Mark K; Department of Psychiatry and Psychotherapy, LMU Hospital, LMU Munich, Munich, Germany., Biechele G; Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany.; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany., Wagner J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Biomedical Center (BMC), Biochemistry, Faculty of Medicine, LMU Munich, Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), Munich, Germany., Guersel S; Department of Psychiatry and Psychotherapy, LMU Hospital, LMU Munich, Munich, Germany., Kurz CI; Department of Psychiatry and Psychotherapy, LMU Hospital, LMU Munich, Munich, Germany., Schweiger M; Department of Psychiatry and Psychotherapy, LMU Hospital, LMU Munich, Munich, Germany., Prtvar D; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Shi Y; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany., Banati RB; Brain and Mind Centre, Medical Imaging Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Liu GJ; Brain and Mind Centre, Medical Imaging Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Australian Nuclear Science and Technology Organisation (ANSTO), Sydney, NSW, Australia., Middleton RJ; Australian Nuclear Science and Technology Organisation (ANSTO), Sydney, NSW, Australia., Mitteregger-Kretzschmar G; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany., Perneczky R; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Psychiatry and Psychotherapy, LMU Hospital, LMU Munich, Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), Munich, Germany.; Ageing Epidemiology Research Unit (AGE), School of Public Health, Imperial College London, London, UK.; Division of Neuroscience, University of Sheffield, Sheffield, UK., Koeglsperger T; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany., Neher JJ; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Biomedical Center (BMC), Biochemistry, Faculty of Medicine, LMU Munich, Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), Munich, Germany., Tahirovic S; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Brendel M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), Munich, Germany.; German Cancer Consortium (DKTK), Munich, Germany., Herms J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), Munich, Germany., Paeger L; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. lars.paeger@dzne.de.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany. lars.paeger@dzne.de.; Munich Cluster for Systems Neurology (Synergy), Munich, Germany. lars.paeger@dzne.de.
Source: Nature communications [Nat Commun] 2025 Aug 08; Vol. 16 (1), pp. 7338. Date of Electronic Publication: 2025 Aug 08.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2041-1723
DOI:10.1038/s41467-025-62500-8